Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Verisign Reports Second Quarter 2025 Results
-
RxSight, Inc. to Report Second Quarter 2025 Financial Results on August 7, 2025
-
B&G Foods Announces Date of Second Quarter 2025 Earnings Conference Call
-
AST SpaceMobile Announces Proposed Private Offering of $500.0 Million of Convertible Senior Notes Due 2032
-
Highwoods Declares Quarterly Dividends
-
Safehold Closes Ground Lease for Affordable Housing Development in San Diego
-
Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call
-
Guild Holdings Company Announces Second Quarter 2025 Earnings Details
-
WM Technology, Inc. to Announce Second Quarter 2025 Financial Results via Webcast
-
AST SpaceMobile Announces Proposed Repurchase of up to $135.0 Million Convertible Senior Notes to be Funded by Concurrent Registered Direct Offering of Class A Common Stock
-
Sight Sciences to Report Second Quarter 2025 Financial Results on August 7, 2025
-
Teknova to Report Second Quarter 2025 Financial Results on August 7, 2025
-
OPKO Health to Report Second Quarter 2025 Financial Results on July 31
-
The Oncology Institute Announces Second Quarter 2025 Earnings Release Date and Conference Call
-
RxSight, Inc. to Report Second Quarter 2025 Financial Results on August 7, 2025
-
Treace to Report Second Quarter 2025 Financial Results on August 7, 2025
-
Peloton Interactive, Inc. Announces Date of Fourth Quarter & Fiscal Year 2025 Earnings Release and Conference Call
-
Capital Clean Energy Carriers Corp. Declares Quarterly Dividend
-
ACM Research Announces Major Upgrades to Its Ultra C wb Wet Bench Cleaning Tool for Advanced Chip Manufacturing
-
Definitive Healthcare Announces Timing of Its Second Quarter 2025 Financial Results Conference Call and Webcast
-
Iovance Biotherapeutics to Host Second Quarter and First Half 2025 Financial Results and Corporate Updates Webcast on Thursday, August 7, 2025
-
GGL Resources Corp. Announces Closing of Initial Tranche of Private Placement
-
Dynagas LNG Partners LP Declares Cash Distribution on Its Series A Preferred Units
-
Preclinical Data Demonstrate Anti-Siglec-15 Treatment Improves Bone Microarchitecture and Reduces Fracture Incidence in Mice with Moderate-to-Severe Osteogenesis Imperfecta
-
Spectrum Wine Generates $1.4 Million in Sales During its Stack’s Bowers Galleries’ Griffin Studios Summer Auction
-
Teads to Release Second Quarter 2025 Financial Results on August 7, 2025
-
NETSTREIT Corp. Announces Launch of Public Offering of Common Stock
-
COLUMBIA BANKING SYSTEM, INC. REPORTS SECOND QUARTER 2025 RESULTS
-
The Manitowoc Company Schedules Second-quarter 2025 Earnings Announcement and Conference Call
-
Data I/O Reports Second Quarter 2025 Results
-
1st Source Corporation Reports Second Quarter Results, Cash Dividend Declared
-
Credit Acceptance Announces Timing of Second Quarter 2025 Earnings Release and Webcast
-
Cumulus Media Announces Conference Call to Discuss Second Quarter 2025 Operating Results
-
Pacific Premier Bancorp, Inc. Announces Second Quarter 2025 Financial Results and a Quarterly Cash Dividend of $0.33 Per Share
-
Warburg Pincus and Berkshire Partners Complete Acquisition of TRIUMPH
-
South Atlantic Bancshares, Inc. Reports Earnings of $0.48 per Diluted Common Share for the Three Months Ended June 30, 2025
-
Scholastic Reports Fourth Quarter and Fiscal 2025 Results
-
Intel Reports Second-Quarter 2025 Financial Results
-
Vaxart Submits Proxy Statement for Reverse Stock Split to Support Resumption of Trading on Nasdaq
-
MAGYAR BANCORP, INC. ANNOUNCES THIRD QUARTER FINANCIAL RESULTS AND DECLARES DIVIDEND
-
SkyWest, Inc. Announces Second Quarter 2025 Profit
-
Brown-Forman Stockholders Elect Directors, Farrer Named Chairman
-
Spruce Biosciences Announces Reverse Stock Split
-
Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on August 11, 2025
-
UWM Holdings Corporation Announces Q2 2025 Earnings Conference Call
-
Celcuity Announces First Patient Dosed in Phase 3 VIKTORIA-2 Clinical Trial of Gedatolisib as a First-Line Treatment for HR+/HER2- Advanced Breast Cancer
-
Atlantic Union Bankshares Corporation Declares Quarterly Common Stock Dividend and Preferred Stock Dividend
-
Kiniksa Pharmaceuticals to Report Second Quarter 2025 Financial Results on July 29, 2025
-
Woodward Announces Declaration of Dividend
-
Shore Bancshares, Inc. Reports 2025 Second Quarter Results
